Yixintang's de facto controller transfers shares to daughters

Yixintang Pharmaceutical Group announced that its controlling shareholder and de facto controller, Ruan Hongxian, intends to transfer 11,712,082 shares, representing 2% of the company's total share capital, to his daughters Ruan Shengxiang and Ruan Aixiang. Each daughter will receive 5,856,041 shares, equivalent to 1% of the total share capital, through block trades within three months following 15 trading days from the announcement date.

The transfers are described as part of a family asset planning strategy. After the transfer, Ruan Hongxian will sign "acting in concert agreements" with both daughters, ensuring no change in the company's control, governance, or continuous operations. The shares originate from those held before the company's initial public offering and listing. The transfer period is set from November 28, 2025, to February 27, 2026.

The transaction is subject to compliance review by the Shenzhen Stock Exchange and share transfer procedures with China Securities Depository and Clearing Corporation Limited. The company will disclose updates on the progress of the planned share transfer.